Investment Thesis
iSpecimen is experiencing severe financial distress with revenue collapsing 79% YoY to just $156K while burning $3.4M in quarterly operating cash. The company faces imminent liquidity crisis with only ~$2.8M cash and less than a quarter's runway at current burn rates, compounded by dangerously high 4.22x debt-to-equity leverage and a current ratio of 0.62x indicating inability to meet short-term obligations.
Strengths
- Net loss improved 16% YoY (from $2.8M to $2.3M), indicating cost reduction efforts
- Retains $2.8M cash buffer providing minimal runway for operational restructuring
- Operates in specialized biospecimen market with potential recovery if customer base stabilizes
Risks
- Catastrophic revenue decline of 79% YoY signals loss of core customer relationships and market viability
- Liquidity crisis: current ratio 0.62x and quick ratio 0.61x indicate inability to cover current liabilities; negative $3.4M quarterly operating cash flow exhausts remaining cash within months
- Extreme financial leverage at 4.22x debt-to-equity with $3.4M long-term debt against only $814K equity; high covenant breach and restructuring risk
- Negative operating margin of -1627% and negative cash conversion indicates fundamental business model failure
- Zero insider Form 4 activity in 90 days suggests management lacks confidence in company survival
Key Metrics to Watch
- Cash runway and monthly burn rate (critical indicator of solvency timeline)
- Revenue stabilization and customer concentration metrics (validating business continuity)
- Debt covenant compliance status and refinancing needs (restructuring risk)
- Operating cash flow trend (indicates whether losses are stabilizing or accelerating)
Financial Metrics
Revenue
156.0K
Net Income
-2.3M
EPS (Diluted)
$-6.66
Free Cash Flow
-3.4M
Total Assets
6.6M
Cash
2.8M
Profitability Ratios
Gross Margin
N/A
Operating Margin
-1,627.1%
Net Margin
-1,458.4%
ROE
-279.5%
ROA
-34.4%
FCF Margin
-2,155.2%
Balance Sheet & Liquidity
Current Ratio
0.62x
Quick Ratio
0.61x
Debt/Equity
4.22x
Debt/Assets
87.7%
Interest Coverage
-141.02x
Long-term Debt
3.4M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-20T07:39:29.111059 |
Data as of: 2026-03-31 |
Powered by Claude AI